Researchers are excited about the medication , a innovative dual treatment showing promising outcomes in early trials for body loss . It functions by impacting two pathways : GLP-1 and GIP, these, when https://lexievmhf799498.blog4youth.com/41293265/the-new-prospect-for-body-loss